28th Jul 2021 18:10
Ap24
AMENDMENT
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 30 June 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
1,259,467 | 10.7109 GBP | 10.6900 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
1,254,997 | 10.7150 GBP | 10.6740 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a long position
Opening a short position
| 38 21,463
499 11,763 1,586 19,591 2,539 2,539 863 8,415
224 1,873 497 8,450 45
261,866 200,000 23,000 677,400 376
3,366 135,092 244 451 3,122 1,336 14,273 283
135,074 600 8,234 14,259 | 10.6988 GBP 10.7097 GBP
10.6740 GBP 10.6889 GBP 10.6898 GBP 10.6974 GBP 10.6991 GBP 10.6992 GBP 10.6996 GBP 10.7103 GBP
10.6893 GBP 10.6898 GBP 10.6901 GBP 10.6913 GBP 10.6998 GBP
10.6943 GBP 10.6954 GBP 10.6980 GBP 10.7100 GBP 10.7104 GBP
10.6895 GBP 10.6900 GBP 10.6935 GBP 10.6960 GBP 10.6975 GBP 10.6986 GBP 10.6994 GBP 10.6996 GBP
10.6900 GBP 10.6951 GBP 10.7001 GBP 10.7109 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 28 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L